Current Vaccine Trials in Glioblastoma: A Review

Glioblastoma (GBM) is the most common primary brain tumor, and despite aggressive therapy with surgery, radiation, and chemotherapy, average survival remains at about 1.5 years. The highly infiltrative and invasive nature of GBM requires that alternative treatments for this disease be widespread and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Linda W., Chow, Kevin K. H., Lim, Michael, Li, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996322/
https://www.ncbi.nlm.nih.gov/pubmed/24804271
http://dx.doi.org/10.1155/2014/796856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996322/
https://www.ncbi.nlm.nih.gov/pubmed/24804271
http://dx.doi.org/10.1155/2014/796856

Ejemplares similares